Tracking Second-Gen Hepatitis C DAAs

All people receiving a first dispensing of the following second-generation DAAs during the DAA period were identified: sofosbuvir (SOF), simeprevir (SMV), daclatasvir (DCV), sofosbuvir/ledipasvir (SOF/LDV), ombitasvir/paritaprevir/ritonavir (OBV/PTVr), dasabuvir (DSV), elbasvir/grazoprevir (EBR/GZR), sofosbuvir/velpatasvir (SOF/VEL), glecaprevir/pibrentasvir (GLE/PIB), sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX). Initiation was defined as the dispensing of DAAs in the absence of any DAA delivery in the previous 6 months. DAAs were identified using a list of medicines based on the Anatomical Therapeutic Chemical classification.

Free full text: Click here

Brouard C., Schwager M., Expert A., Drewniak N., Laporal S., de Lagasnerie G, & Lot F. (2024). Impact of Public Policy and COVID-19 Pandemic on Hepatitis C Testing and Treatment in France, 2014–2021. Viruses, 16(5), 792.

Publication 2024

Corresponding Organization : Santé Publique France

Other organizations : l'Assurance Maladie

Top 5 similar protocols

Variable analysis

independent variables

Dispensing of the following second-generation DAAs during the DAA period: sofosbuvir (SOF), simeprevir (SMV), daclatasvir (DCV), sofosbuvir/ledipasvir (SOF/LDV), ombitasvir/paritaprevir/ritonavir (OBV/PTVr), dasabuvir (DSV), elbasvir/grazoprevir (EBR/GZR), sofosbuvir/velpatasvir (SOF/VEL), glecaprevir/pibrentasvir (GLE/PIB), sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX)

dependent variables

Initiation of DAA treatment, defined as the dispensing of DAAs in the absence of any DAA delivery in the previous 6 months

control variables

Not explicitly mentioned

positive controls

Not mentioned

negative controls

Not mentioned

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!